Blockchain Registration Transaction Record

Tonix's TNX-1500 Phase 1 Data Published: Promising Step for Kidney Transplant

Tonix Pharmaceuticals announces publication of Phase 1 data for TNX-1500 in Journal of Clinical Immunology, showing safety and tolerability, supporting advancement to Phase 2 kidney transplant rejection study.

Tonix's TNX-1500 Phase 1 Data Published: Promising Step for Kidney Transplant

This news matters because it showcases the progress of TNX-1500, a potential new treatment to prevent kidney transplant rejection, a critical unmet need. With Phase 1 data demonstrating safety and tolerability, and a clear path to Phase 2 trials, this could offer hope for thousands of patients awaiting or living with kidney transplants. For investors, positive clinical data strengthens Tonix's immunology pipeline and may enhance the company's valuation.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x44db3808b616057b00f93f86216fef3509a85696f918586dba475a088724102c
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintfrogou8X-6d8b72656402acfedf34833732ece6c5